iTeos Therapeutics, Inc. (ITOS) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts ITOS Hot Sheet
Join SI Premium – FREE
iTeos Therapeutics, Inc. (NASDAQ: ITOS) reported Q2 EPS of ($0.96), $0.04 better than the analyst estimate of ($1.00).
For earnings history and earnings-related data on iTeos Therapeutics, Inc. (ITOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- Xilio Therapeutics, Inc. (XLO) Tops Q2 EPS by 25c
- PolyPid Ltd. (PYPD) Tops Q2 EPS by 5c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
